Table 3.
Overall treatments received by AA patients throughout the study period (from baseline to end of follow-up)
| Regimen | SAA (n = 209) | VSAA (n = 83) | TH-NSAA (n = 48) | Total (n = 340) |
|---|---|---|---|---|
| HSCT containing | 38 (18.2) | 18 (21.7) | 4 (8.3) | 60 (17.6) |
| IST containing | 186 (89.0) | 72 (86.7) | 45 (93.8) | 303 (89.1) |
| TCM containing | 56 (26.8) | 16 (19.3) | 7 (14.6) | 79 (23.2) |
| Supportive care containing | 207 (99.0) | 83 (100.0) | 39 (81.3) | 329 (96.8) |
| Androgen monotherapy containing | 8 (3.8) | 0 | 1 (2.1) | 9 (2.6) |
| Others | 15 (7.2) | 8 (9.6) | 2 (4.2) | 25 (7.4) |
Data are presented asn (%). Patients may have received more than 1 treatment. AA, anaplastic anemia; SAA, severe AA; VSAA, very severe AA; TD-NSAA, transfusion-dependent non-severe AA; HSCT, hematopoietic stem-cell transplantation; IST, immunosuppressive therapy; TCM, traditional Chinese medicine.